NTRA - Conference and earnings call announcements

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, Jan. 13, 2026 at 4:30 p.m. PT (7:30 p.m. ET). Members of management will deliver a presentation and host a Q&A with the investment community at the conference. A live webcast may be accessed through the investor relations section of the Natera website at investor.natera.com. A replay of the event will be available shortly following the conference. About Natera Natera™ is a global leader in cell-free DNA and precision medicine, dedicated to oncology, women's health, and organ heal

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing, today announced that it will participate in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, Jan. 15, 2025 at 9:00 a.m. PT (12:00 p.m. ET). Members of management will deliver a presentation and host a Q&A with the investment community at the conference. A live webcast may be accessed through the investor relations section of the Natera website at investor.natera.com. A replay of the event will be available shortly following the conference. About Natera Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women's health, and organ health. We aim t

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and genetic testing, today announced that members of its leadership team will present at the following investor conferences in November and December. The UBS Global Healthcare Conference on Thursday, Nov. 14 at 11:00 am ET | 8:00 am PT in Rancho Palos Verdes, CA. The Wolfe Research Healthcare Conference on Tuesday, Nov. 19 at 11:00 am ET | 8:00 am PT in New York, NY. The 36th Annual Piper Sandler Healthcare Conference on Tuesday, Dec. 3 at 8 am ET | 5 am PT in New York, NY. A live webcast and audio archive of these events can be accessed through the investor relations section of the Natera website at investor.natera.com. A

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and genetic testing, today announced that members of its leadership team will present at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, Sept. 4 at 2:35 pm ET | 11:35 am PT in New York City. A live webcast and audio archive of the event may be accessed through the investor relations section of the Natera website at investor.natera.com. A replay of the event will be available shortly following the conference. About Natera Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women's health, and organ health. We aim to make personalized genetic testing and diagnostics

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing, today announced that members of its leadership team will present at the Canaccord Genuity 44th Annual Growth Conference on Wednesday, Aug. 14 at 12:30 pm ET | 9:30 am PT in Boston, MA. A live webcast and audio archive of the event may be accessed through the investor relations section of the Natera website at investor.natera.com. A replay of the event will be available shortly following the conference. About Natera Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women's health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard o

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced that its latest research and data on prenatal and reproductive genetics will be presented at the 28th International Conference on Prenatal Diagnosis and Therapy. Hosted by the International Society of Prenatal Diagnosis (ISPD), the conference will take place July 7-10, 2024, in Boston, MA. Below is the list of poster presentations that will be shared at the conference: Poster Presentation | Presenter: India Bradley, MS, CGC | July 8, 3:30 PM ET Importance of evaluation of discordant sex between SNP-based NIPT and prenatal ultrasound: A case of congenital lipoid adrenal hyperplasia

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024 at 7:40 a.m. PT (10:40 a.m. ET). A live webcast may be accessed through the investor relations section of the Natera website at investor.natera.com. A replay of the event will be available shortly following the conference. About Natera Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women's health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, mo

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and genetic testing, today announced that members of Natera's management will present at the 2024 Leerink Partners Healthcare Crossroads Conference on Thursday, May 30, 2024 at 8:40 a.m. PT (11:40 a.m. ET). A live webcast may be accessed through the investor relations section of the Natera website at investor.natera.com. A replay of the event will be available shortly following the conference. About Natera Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women's health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing, today announced that it will participate in the following investor conferences in March. Raymond James 45th Annual Institutional Investors Conference Tuesday, March 5 at 2:15 pm ET | 11:15 am PT in Orlando, FL TD Cowen 44th Annual Health Care Conference Wednesday, March 6 at 9:50 am ET | 6:50 am PT in Boston, MA A live webcast and audio archive of each event may be accessed through the investor relations section of the Natera website at investor.natera.com. Replays of the events will be available shortly following the conferences. About Natera Natera™ is a global leader in cell-free DNA testing, dedicated to

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing, today announced that it will participate in the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, Jan. 9, 2024 at 3:45 p.m. PT (6:45 p.m. ET). Members of Natera's management will deliver a presentation and host a Q&A with the investment community at the conference. A live webcast may be accessed through the investor relations section of the Natera website at investor.natera.com. A replay of the event will be available shortly following the conference. About Natera Natera™ is a global leader in cell-free DNA testing, dedicated to oncology, women's health, and organ health. We aim to make

Study to evaluate effectiveness of switching treatment to elacestrant in early breast cancer based on the detection of molecular relapse with Signatera™ Approximately 1,900 early-stage breast cancer patients to be screened at 120+ sites in Europe Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing, today announced its personalized and tumor-informed molecular residual disease (MRD) test, Signatera, will be used in a new breast cancer study called TREAT ctDNA (EORTC 2129-BCG). This international, multi-center, randomized, phase III clinical trial is being conducted by the European Organisation for Research and Treatment of Cancer (EORTC) Breast Cancer Group in collaborat

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing, today announced that it will participate in the following investor conferences in November. • Stephens Annual Investment Conference   Tuesday, Nov. 14 at 12:00 pm ET | 9:00 am PT in Nashville, TN     • Piper Sandler 35th Annual Healthcare Conference   Tuesday, Nov. 28 at 2:30 pm ET | 11:30 am PT in New York, NY A live webcast and audio archive of each event may be accessed through the investor relations section of the Natera website at investor.natera.com. Replays of the events will be available shortly following the conferences. About Natera

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing, today announced that members of its management team will present at the following investor conferences: The Morgan Stanley 21st Annual Global Healthcare Conference on Monday, Sept. 11 at 4:55 p.m. ET in New York, NY The Baird 2023 Global Healthcare Conference on Tuesday, Sept. 12 at 4:20 p.m. ET in New York, NY A live webcast and audio archive of each event may be accessed through the investor relations section of the Natera website at investor.natera.com. Replays will be available shortly thereafter. About Natera Natera™ is a global leader in cell-free DNA testing, dedicated to oncology, women's health, and

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing, today announced that members of its leadership team will present at the Canaccord Genuity 43rd Annual Growth Conference on Wednesday, Aug. 9 at 4:30 pm ET | 1:30 pm PT in Boston, MA. A live webcast and audio archive of the event may be accessed through the investor relations section of the Natera website at investor.natera.com. A replay of the event will be available shortly following the conference. About Natera Natera™ is a global leader in cell-free DNA testing, dedicated to oncology, women's health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to prot

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing, today announced that members of its management team will present at the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13 at 5:40 pm ET | 2:40 pm PT in Dana Point, CA. A live webcast and audio archive of the event may be accessed through the investor relations section of the Natera website at investor.natera.com. A replay of the event will be available shortly following the conference. About Natera Natera™ is a global leader in cell-free DNA testing, dedicated to oncology, women's health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of ca

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing, today announced that members of its management team will present at the following investor conferences: Raymond James 44th Annual Institutional Investors Conference on Tuesday, March 7 at 2:50 p.m. ET in Orlando, FL Cowen 43rd Annual Health Care Conference on Wednesday, March 8 at 11:10 a.m. ET in Boston, MA A live webcast and audio archive of each event may be accessed through the investor relations section of the Natera website at investor.natera.com. A replay of each event will be available shortly following the conferences. About Natera Natera™ is a global leader in cell-free DNA testing, dedicated to oncology

AUSTIN, Texas, Nov. 23, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing, today announced that Steve Chapman, chief executive officer, and Mike Brophy, chief financial officer, will be presenting at the Piper Sandler 34th Annual Healthcare Conference located at the Lotte New York Palace on Wednesday, November 30 at 12:00 p.m. PT (3:00 p.m. ET). Interested parties may access the live webcast of the presentation on the Natera Investor Relations website at investor.natera.com, where the webcast will be archived for future reference. About

AUSTIN, Texas, Nov. 1, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing, today announced that Steve Chapman, chief executive officer, and Mike Brophy, chief financial officer, will be presenting at the Credit Suisse 31st Annual Healthcare Conference on Wednesday, November 9 at 10:25 a.m. PT (1:25 p.m. ET). Interested parties may access the live webcast of the presentation on the Natera Investor Relations website at investor.natera.com, where the webcast will be archived for future reference. About Natera Natera™ is a global leader in ce

AUSTIN, Texas, Sept. 6, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing, today announced that Steve Chapman, chief executive officer, and Mike Brophy, chief financial officer, will be presenting at the following upcoming investor conferences: Morgan Stanley Global Healthcare Conference on Tuesday, Sept. 13 at 4:05 pm ET.Baird 2022 Global Healthcare Conference on Wednesday, Sept. 14 at 2:00 pm ET.Interested parties may access live and archived webcasts of the presentation on the Natera Investor Relations website at investor.natera.com,

AUSTIN, Texas, July 14, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced it has been selected to participate in UnitedHealthcare's Preferred Laboratory Network (PLN). Natera's addition to the network was effective July 1, 2022. UnitedHealthcare's PLN consists of laboratory care providers that have met the insurer's highest standards for access, cost, data, quality and service, based on a rigorous application and review process. UnitedHealthcare works with these labs to continue its efforts to improve the care pr

AUSTIN, Texas, Feb. 15, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing, today announced that Steve Chapman, chief executive officer, and Mike Brophy, chief financial officer, will provide an update on recent business activities in the following upcoming investor conferences. 11th Annual SVB Leerink Global Health Care Conference Date: February 16, 2022 Time: 1:00 p.m. ET Presenters: Steve Chapman and Mike Brophy Cowen 42nd Annual Health Care Conference Date: March 8, 2022 Time: 2:50 p.m. ET Presenters: Steve Chapman and Mike Brophy Ra

AUSTIN, Texas, Aug. 10, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ:NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the company's leadership will participate in several upcoming investor conferences. Steve Chapman, chief executive officer, and Mike Brophy, chief financial officer, will discuss recent business activities, the continued and significant growth of Natera in the genetic testing industry and the impact the company is making on people's lives. Details are as follows: Canaccord Genuity 41st Annual Growth Conference Date:                

AUSTIN, Texas, May 28, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ:NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, today announced it has been sued by Guardant Health, in an attempt to stop Natera from exposing Guardant Reveal's™ true test performance and the differences between tumor-informed and tumor-naive molecular residual disease (MRD) tests. Natera has filed a claim against Guardant in the U.S. District Court for the Western District of Texas, (Docket No.6:21-cv-00540), alleging that Guardant used false and misleading claims to deceive physicians abo

SAN CARLOS, Calif., Feb. 23, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will webcast a live presentation at the Cowen 41st Annual Health Care Conference on Tuesday, March 2, 2021 at 11:10 a.m. PT (2:10 p.m. ET). Mike Brophy, Chief Financial Officer, will provide an overview of the company and discuss recent business activities, followed by a question and answer session. Access to the live webcast and subsequent archived presentation will be available at investor.natera.com. About Natera Natera is a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to c

SAN CARLOS, Calif., Feb. 11, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that Alexey Aleshin, MD, Natera's Senior Medical Director of Oncology, will participate in a panel discussion at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference. Additionally, Steve Chapman, CEO, and Mike Brophy, CFO, will participate in a fireside chat at the 10th Annual SVB Leerink Global Healthcare Conference. Details are as follows: BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference Date: Thursday, February 18, 2021 Time: 10:00 a.m. PT (1:00 p.m.